HRMY

Harmony Biosciences Holdings, Inc.NASDAQHealthcare

$27.74-0.79%ClosedMarket Cap: $1.60B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-02-25	Needham	—	Buy	—
2026-02-25	B of A Securities	—	Underperform	—
2026-02-25	HC Wainwright & Co.	—	Buy	—
2026-02-25	UBS	—	Neutral	—
2026-01-08	Truist Securities	—	Buy	—
2025-12-01	Mizuho	—	Outperform	—
2025-11-24	Needham	—	Buy	—
2025-11-24	HC Wainwright & Co.	—	Buy	—
2025-10-15	UBS	—	Buy	—
2025-09-25	Mizuho	—	Outperform	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$4.22	$1.15B	6
Sun Dec 31	$4.87	$1.22B	9
Mon Dec 31	$5.17	$1.26B	3
Tue Dec 31	$4.53	$1.06B	3